Thank you, Mr. Chair.
The question I have is around COVAX. The understanding was that COVAX was intended to be used as a tool to make sure that vaccines were equitably distributed.
Mr. Tabah, do you believe that it undermines COVAX's ability to do its job, when other countries develop bilateral agreements with the vaccine producers and, in effect, take the vaccines that would be available, so COVAX can't do its job?